Ikarian Capital, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 292 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$4,635,800
-69.8%
130,000
-35.0%
0.74%
+9.0%
Q4 2020$15,346,000
+137.6%
200,000
+33.3%
0.68%
+45.0%
Q3 2020$6,459,000
+3020.3%
150,000
+1983.3%
0.47%
+2818.8%
Q1 2020$207,000
-98.4%
7,200
-96.4%
0.02%
-99.2%
Q4 2019$12,686,000200,0002.06%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders